Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents - Siberia

NCT03951727 is registered in ClinicalTrials.gov with Meshalkin Research Institute of Pathology of Circulation as lead sponsor.

NCT NCT03951727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03951727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents - Siberia
Lead sponsor
Meshalkin Research Institute of Pathology of Circulation
Phase
Not applicable
Overall status
Unknown status
Start date
May 13, 2019
Completion date
May 13, 2022
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, peripheral arterial disease, superficial femoral artery occlusion